|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 160 of 212 found articles
| Title: |
11P Results of a phase II study investigating eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in second-line PD-1/PD-L1 refractory metastatic non-small cell lung carcinoma pts |
| Author: |
Krebs, M.G. Majem Tarruella, M. Forster, M. Peguero, J.A. Clay, T. Felip, E. Iams, W. Roxburgh, P. Doger de Spéville, B. Bajaj, P. Mueller, C. Triebel, F. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S2 pages S33 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 160 of 212 found articles
| << previous | next >> |